Use of insulin glargine during pregnancy
Open Access
- 1 October 2007
- journal article
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 86 (10), 1171-1174
- https://doi.org/10.1080/00016340701515282
Abstract
Background. Good metabolic control maintained throughout pregnancy reduces maternal and fetal complications in diabetic women. The long-acting insulin analogue glargine has 24-h persistence and a peakless action profile, and could contribute to more stable daily plasma glucose levels and improved glycemic control. We evaluated the metabolic control associated with insulin glargine during pregnancy in comparison with conventional basal insulin therapy. Methods. Retrospective case-control analysis of glycemic control and pregnancy complications in 100 type 1 diabetic pregnancies with intermediate-acting NPH insulin or insulin glargine prior to conception and throughout pregnancy. Results. Overall, glycemic control was not different between the groups, though the decrease in HbA1c from the first to the third trimester was greater with insulin glargine (0.8 versus 0.3%, p = 0.04). The rate of hypoglycemia was comparable. Conclusions. Our findings suggest that, as regards metabolic control, insulin glargine in women with type 1 diabetes is comparable with NPH insulin as basal insulin therapy. No adverse effects were associated with glargine use at the time of conception and during pregnancy.Keywords
This publication has 18 references indexed in Scilit:
- Use of insulin glargine during pregnancy: a case-control pilot studyBJOG: An International Journal of Obstetrics and Gynaecology, 2007
- The Use of Insulin Glargine With Gestational Diabetes MellitusDiabetes Care, 2006
- Insulin therapy in pregnancy complicated by diabetes: are insulin analogs a new tool?Diabetes/Metabolism Research and Reviews, 2005
- Insulin AnaloguesNew England Journal of Medicine, 2005
- Better long‐term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal‐time lispro insulinDiabetic Medicine, 2004
- Preconception Care of Women With DiabetesDiabetes Care, 2004
- A review of basal insulinsDiabetic Medicine, 2003
- Why Do Diabetic Women Deliver Malformed Infants?Clinical Obstetrics and Gynecology, 2000
- Pregnancy outcomes in the Diabetes Control and Complications TrialAmerican Journal of Obstetrics and Gynecology, 1996
- Type I diabetes mellitus and pregnancyThe Lancet, 1995